Difference between revisions of "Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5 (Q9979)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created a new Item: #quickstatements; #temporary_batch_1589975872009)
 
(‎Created claim: Page(s) (P105): 86-95, #quickstatements; #temporary_batch_1590074839150)
 
(8 intermediate revisions by the same user not shown)
Property / First Author string
 +
Li X
Property / First Author string: Li X / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1016/j.imlet.2017.01.010 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 28153605 / rank
 +
Normal rank
Property / Publication Date
 +
2017
Timestamp+2017-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2017 / rank
 +
Normal rank
Property / Published In Name String
 +
Immunol. Lett.
Property / Published In Name String: Immunol. Lett. / rank
 +
Normal rank
Property / Volume
 +
183
Property / Volume: 183 / rank
 +
Normal rank
Property / title
 +
CD19 from bench to bedside (English)
Property / title: CD19 from bench to bedside (English) / rank
 +
Normal rank
Property / Page(s)
 +
86-95
Property / Page(s): 86-95 / rank
 +
Normal rank
links / sliswiki / namelinks / sliswiki / name
 +

Latest revision as of 15:50, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Li X
    0 references
    0 references
    2017
    0 references
    Immunol. Lett.
    0 references
    183
    0 references
    CD19 from bench to bedside (English)
    0 references
    86-95
    0 references